John Skubic, MD
Orthopaedic Surgery · Redlands, CANPI 1164461224
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $626,985 of the $764,235 with a category attached, or 82.0%. Inland Surgical Products, LLC accounts for 82.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $625,825 and has fallen 98.6% since, to $9,031 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $58,787 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inland Surgical Products, LLC$627K
- Kyocera Medical Technologies, Inc.$86K
- Renovis Surgical Technologies, Inc.$51K
- Nevro Corp.$11
Across 31 payments — averaging $402.96 each. An ownership or investment interest held by the physician or an immediate family member.
- Midwest Surgical Alliance, LLC$8K
- Central California Surgical Distributors, LLC$2K
- Sequoia Surgical Distributors, LLC$2K
- Senate Surgical Distribution, LLC$0
- North Idaho Surgical Cooperative, LLC$0
- Alpine Implant Alliance, LLC$0
What the payments were for
- Royalty or licence$111,73915%
- Consulting fees$25,5003%
- Food & beverage$110%
- Ownership interest$626,98582%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inland Surgical Products, LLC | 2 | $626,985 |
| Kyocera Medical Technologies, Inc. | 9 | $86,302 |
| Renovis Surgical Technologies, Inc. | 1 | $50,937 |
| Nevro Corp. | 1 | $11 |
How this compares
$764,235 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 88 | $1,716 |
| Gabapentin | 28 | $201 |
| Tramadol Hcl | 29 | $70 |
| Prednisone | 28 | $64 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Redlands
- Paul BurtonRedlands$646K
- Bradford HackArcadia$18.3M
- Robert GorabOrange$13.6M
- Kelly VinceLos Angeles$9.6M
- Stephen HowellSacramento$9.4M
- Thomas CoonRed Bluff$9.2M
- Nirav AminPlacentia$5.6M
- Tom NorrisSan Francisco$5.3M
- Jay LiebermanLos Angeles$4.8M
- Peter NewtonSan Diego$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.